Veeva Systems Inc (VEEV)
NYSE:VEEV
Want to see VEEV full AI Analyst Report?
VEEV Stock Chart & Stats
$167.95
$3.27(1.54%)
At close: 4:00 PM EST
$167.95
$3.27(1.54%)
Day’s Range― - ―
52-Week Range$148.05 - $310.50
Previous CloseN/A
Volume260.89K
Average Volume (3M)4.05M
Market Cap
$25.92B
Enterprise Value$27.12B
Total Cash (Recent Filing)$7.31B
Total Debt (Recent Filing)$103.07M
Price to Earnings (P/E)27.7
Beta0.89
Next Earnings
Sep 02, 2026EPS Estimate
2.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.76
Shares Outstanding162,443,300
10 Day Avg. Volume3,333,228
30 Day Avg. Volume4,048,423
Financial Highlights & Ratios
PEG Ratio1.42
Price to Book (P/B)4.63
Price to Sales (P/S)10.44
P/FCF Ratio24.08
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue8.17
Enterprise Value/Gross Profit10.90
Enterprise Value/Ebitda21.06
Forecast
1Y Price Target
$236.68Price Target Upside40.93% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering21
EPS Forecast (FY)9.05
Revenue Forecast (FY)$3.60B
Bulls Say, Bears Say
Bulls Say
High ProfitabilitySustained high gross and net margins reflect durable pricing power in life‑sciences software and data. Margin strength supports reinvestment in R&D and sales, enabling long‑term product development and customer support without relying on one‑off gains.
Conservative Balance SheetVery low leverage gives Veeva resilience to macro shocks and funding flexibility for M&A or product investment. A conservative capital structure reduces solvency risk and preserves capacity to invest in strategic initiatives over multiple years.
Product Traction & Competitive MoatStrong Vault CRM adoption and a >80% win rate indicate entrenched product-market fit and high switching costs in regulated pharma workflows. Continued migrations and marquee wins reinforce Veeva’s durable enterprise moat and expansion potential within existing accounts.
Bears Say
Free Cash Flow WeaknessA sudden drop in free cash flow conversion reduces available internal capital for buybacks, acquisitions, or extra R&D. If conversion issues persist, liquidity dynamics could constrain strategic flexibility and increase sensitivity to operating volatility.
Revenue Growth DecelerationSlowing top‑line growth from prior mid‑teens rates limits long‑term operating leverage and could compress future margin expansion. Persistent deceleration would challenge the company’s ability to sustain prior EPS growth without material margin or revenue diversification gains.
Early-Stage AI Execution RiskMajor agentic AI initiatives like Falcon need platform buildout, compliance validation, and customer training before scaling. Execution risk and slow monetization could divert R&D spend and delay returns, limiting near‑term impact on durable revenue and margins.
Veeva Systems News
VEEV FAQ
What was Veeva Systems Inc’s price range in the past 12 months?
Veeva Systems Inc lowest stock price was $148.05 and its highest was $310.50 in the past 12 months.
What is Veeva Systems Inc’s market cap?
Veeva Systems Inc’s market cap is $25.92B.
When is Veeva Systems Inc’s upcoming earnings report date?
Veeva Systems Inc’s upcoming earnings report date is Sep 02, 2026 which is in 79 days.
How were Veeva Systems Inc’s earnings last quarter?
Veeva Systems Inc released its earnings results on Jun 03, 2026. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.139 by $0.101.
Is Veeva Systems Inc overvalued?
According to Wall Street analysts Veeva Systems Inc’s price is currently Undervalued.
Does Veeva Systems Inc pay dividends?
Veeva Systems Inc does not currently pay dividends.
What is Veeva Systems Inc’s EPS estimate?
Veeva Systems Inc’s EPS estimate is 2.22.
How many shares outstanding does Veeva Systems Inc have?
Veeva Systems Inc has 162,443,300 shares outstanding.
What happened to Veeva Systems Inc’s price movement after its last earnings report?
Veeva Systems Inc reported an EPS of $2.24 in its last earnings report, beating expectations of $2.139. Following the earnings report the stock price went down -0.067%.
Which hedge fund is a major shareholder of Veeva Systems Inc?
Currently, no hedge funds are holding shares in VEEV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Veeva Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$236.68 (40.93% Upside)
$236.68 (40.93% Upside)
Blogger Sentiment
Bullish
VEEV Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 0.8%
Last 30 Days ▲ 4.2%
Last 30 Days ▲ 4.2%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.45%
12-Months-Change
Fundamentals
Return on Equity
13.41%
Trailing 12-Months
Asset Growth
17.57%
Trailing 12-Months
Company Description
Veeva Systems Inc
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.
VEEV Company Deck
VEEV Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong execution and several clear growth drivers: solid Q1 financials ($883M revenue; $395M non-GAAP operating income), durable momentum in Crossix, a healthy R&D pipeline, Vault CRM traction (150+ live customers, >80% win rate) and strategic M&A (Ostro). Management is investing in AI (Vault AI, Falcon) and new agentic labor offerings, but these are early-stage and expected to have immaterial revenue impact this year outside of Ostro. Margin guidance is conservative and investments in services and AI introduce some near-term cost dynamics. Overall, positive operational momentum and disciplined investment balanced against execution and scaling risk for transformational AI initiatives.View all VEEV earnings summariesVEEV Revenue Breakdown
58.18% North America
27.79% Europe
11.35% APAC
2.68% Middle East, Africa, and Latin America
VEEV Stock 12 Month Forecast
Average Price Target
$236.68
▲(40.93% Upside)
Technical Analysis
Healthequity
―
Doximity
―
GE Healthcare Technologies Inc
―
BrightSpring Health Services, Inc.
―
Tempus AI, Inc. Class A
―
Ownership Overview
1.02% Insiders
24.04% Mutual Funds
22.26% Other Institutional Investors
28.79% Public Companies and Individual Investors